Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
Preferred Name | Biguanide Antidiabetic Agent | |
Synonyms |
|
|
Definitions |
Any antidiabetic agent with the biguanide base structure or phenformin derivatives with antihyperglycemic activity. Biguanide antidiabetic agents activate AMP-activated protein kinase (AMPK) resulting in decreased glucose production in the liver, increased peripheral glucose uptake and improved utilization of glucose. Biguanide-based antidiabetic agents do not cause hypoglycemia. In addition, biguanide antidiabetics decrease absorption of glucose from the gastrointestinal tract. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C98234 |
|
code |
C98234
|
|
Contributing_Source |
GDC
|
|
definition |
Any antidiabetic agent with the biguanide base structure or phenformin derivatives with antihyperglycemic activity. Biguanide antidiabetic agents activate AMP-activated protein kinase (AMPK) resulting in decreased glucose production in the liver, increased peripheral glucose uptake and improved utilization of glucose. Biguanide-based antidiabetic agents do not cause hypoglycemia. In addition, biguanide antidiabetics decrease absorption of glucose from the gastrointestinal tract.
|
|
in_subset | ||
Is_Value_For_GDC_Property | ||
label |
Biguanide Antidiabetic Agent
|
|
Maps_To |
Biguanide
|
|
Preferred_Name |
Biguanide Antidiabetic Agent
|
|
prefixIRI |
NCIT:C98234
|
|
prefLabel |
Biguanide Antidiabetic Agent
|
|
Semantic_Type |
Pharmacologic Substance Chemical Viewed Functionally
|
|
UMLS_CUI |
C3273895
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping
Mapping To | Ontology | Source |
---|---|---|
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C98234 | NCIT | LOOM |